What are the treatment options for thyroiditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Thyroiditis

Treatment of thyroiditis depends on the specific type and phase of disease, with levothyroxine replacement for hypothyroidism, beta-blockers for symptomatic thyrotoxicosis, and NSAIDs or corticosteroids for painful inflammatory thyroiditis. 1

Initial Assessment and Monitoring

Before initiating treatment, measure both TSH and free T4 to determine the phase of thyroid dysfunction and localize the disease 2, 3. This is critical because:

  • Low TSH with low FT4 indicates central hypothyroidism (hypophysitis), requiring evaluation for other pituitary hormone deficiencies 3
  • In patients with both adrenal insufficiency and hypothyroidism, steroids must always be started before thyroid hormone to avoid precipitating adrenal crisis 2, 3
  • Thyroid receptor antibodies should be obtained if clinical features suggest Graves' disease rather than thyroiditis (ophthalmopathy, thyroid bruit, or T3 toxicosis) 3

Treatment by Thyroiditis Type and Phase

Thyrotoxic (Hyperthyroid) Phase

Beta-blockers are the mainstay of symptomatic treatment during the thyrotoxic phase, as thyroiditis is self-limited and does not require antithyroid drugs 1, 3:

  • Initiate propranolol or atenolol for palpitations, tremors, heat intolerance, and other adrenergic symptoms 1
  • Non-selective beta blockers with alpha receptor-blocking capacity are preferred for symptomatic patients 2
  • Continue immune checkpoint inhibitors in drug-induced thyroiditis unless the patient is severely unwell with symptomatic hyperthyroidism 1
  • Consider carbimazole only if anti-TSH receptor antibodies are positive, suggesting Graves' disease rather than thyroiditis 1
  • Monitor thyroid function every 2-3 weeks, as the thyrotoxic phase typically resolves within 4-6 weeks 2, 3
  • Refer to endocrinology if thyrotoxicosis persists beyond 6 weeks 3

Hypothyroid Phase

Levothyroxine replacement is indicated for symptomatic hypothyroidism or TSH >10 mIU/L 2, 1:

Dosing strategy:

  • For patients under 70 years without cardiac disease, frailty, or multiple comorbidities: start full replacement at approximately 1.6 mcg/kg/day based on ideal body weight 2, 1
  • For patients over 70 years or with cardiac disease: start low at 25-50 mcg/day and titrate gradually 1
  • For drug-induced thyroiditis: start thyroxine 0.5-1.5 μg/kg 1

Monitoring and titration:

  • Recheck TSH every 4-6 weeks initially while titrating to maintain TSH in the normal range 2, 3
  • FT4 can help interpret ongoing abnormal TSH levels, as TSH may take longer to normalize 2
  • Once stable, repeat testing every 6-12 months or with symptom changes 2
  • Reduce dose or discontinue if TSH becomes suppressed, suggesting overtreatment or recovery of thyroid function 1

Consider treatment for TSH 4-10 mIU/L if:

  • Patient is symptomatic 1
  • Patient desires fertility 1
  • In postpartum thyroiditis with these features 1

Painful Thyroiditis (Subacute Granulomatous)

NSAIDs or high-dose aspirin provide symptomatic relief for thyroid pain 1:

  • Start with NSAIDs or high-dose aspirin for initial pain management 1
  • For severe disease: prednisone 40 mg daily with gradual taper over several weeks 1
  • Consider prednisolone 0.5 mg/kg with taper for painful drug-induced thyroiditis 1

Special Populations and Contexts

Drug-Induced Thyroiditis (Immune Checkpoint Inhibitors)

  • Continue immune checkpoint inhibitor therapy in most cases 1
  • Withhold immunotherapy only if patient is severely unwell with symptomatic hyperthyroidism 1
  • Monitor thyroid function before every cycle for the first 3 months with anti-PD-1/PD-L1 therapy 1
  • Monitor every cycle with anti-CTLA4 therapy, as late endocrine dysfunction is possible 1

Postpartum Thyroiditis

  • Monitor TSH and FT4 in women who develop goiter or thyroid dysfunction symptoms within one year of delivery, miscarriage, or medical abortion 3
  • Treatment approach follows the same algorithm as other thyroiditis types based on TSH levels and symptoms 1

Critical Pitfalls to Avoid

  • Never start levothyroxine before hydrocortisone in patients with possible central hypothyroidism or hypophysitis, as this precipitates adrenal crisis 2, 3
  • Never start high-dose levothyroxine in elderly patients or those with cardiac disease; always start low and titrate slowly 1
  • Do not use antithyroid drugs for thyroiditis-induced thyrotoxicosis, as it is due to hormone release from damaged cells, not overproduction 2
  • Levothyroxine is not indicated during the recovery phase of subacute thyroiditis 4
  • Do not use radioactive iodine during pregnancy or breastfeeding; it is contraindicated for 4 months post-treatment 1

When to Refer to Endocrinology

Endocrinology consultation is recommended for 2, 1:

  • All cases of suspected or confirmed hypophysitis
  • Unusual clinical presentations
  • Difficulty titrating hormone therapy
  • Concern for central hypothyroidism
  • Thyrotoxicosis persisting beyond 6 weeks 3

Long-Term Considerations

  • Most thyroiditis cases progress from thyrotoxicosis to permanent hypothyroidism after an average of 1 month following the thyrotoxic phase 2
  • Lifelong hormonal replacement is needed in most cases of hypophysitis-related hypothyroidism 2
  • Monitor for progression from subclinical to overt hypothyroidism, particularly in Hashimoto's thyroiditis 1
  • All patients with adrenal insufficiency should obtain and carry a medical alert bracelet 2

References

Guideline

Treatment of Thyroiditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Thyroiditis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.